Medline Industries recalled 8,267,150 saline flush syringes on September 11, 2025. The syringes may not meet the required concentration of sodium chloride. Consumers and healthcare providers must stop using these products immediately.
Medline has identified a limited quantity of saline IV flush syringes that may not meet the required concentration of sodium chloride.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Medline Industries, LP or your healthcare provider for instructions. Notification method: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The recalled product is 0.9% Sodium Chloride Injection, USP, with a 10 mL fill and item number EMZ111240. The syringes were distributed nationwide in the U.S. and Canada.
The recalled saline IV flush syringes may not contain the correct sodium chloride concentration. This poses a risk of improper dosing in medical treatments.
No specific injury reports have been recorded. The high hazard level indicates serious potential risks associated with improper use.
Stop using the recalled syringes immediately. Contact Medline Industries or your healthcare provider for further instructions and guidance.
For more information, call Medline Industries at 1-800-396-2006 or visit their website at https://www.medline.com.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.